NFG
HRMY icon

Nadler Financial Group’s Harmony Biosciences HRMY Stock Holding History

Nadler Financial Group’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$249K Buy
+6,846
New +$216K 0.02% 124
2026
Q1 		– Sell
-7,964
Closed -$298K – 143
2025
Q4 		$298K Sell
7,964
-1,397
-15% -$45.9K 0.03% 110
2025
Q3 		$258K Buy
+9,361
New +$322K 0.02% 113

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nadler Financial Group's HRMY Position: Q2 2026 in Review

Nadler Financial Group opened a new position in Harmony Biosciences (HRMY) in Q2 2026: 6,846 shares worth $249K. The stake represents 0.02% of the portfolio and ranks #124 among its holdings. This is a return to the name: Nadler Financial Group previously reported a position in HRMY as recently as Q4 2025.

Nadler Financial Group first reported a position in HRMY in Q3 2025 and has held it in 3 quarters since. The position peaked at $298K in Q4 2025. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Nadler Financial Group held 6,846 shares of Harmony Biosciences worth $249K as of Q2 2026.
  • Harmony Biosciences was a new Nadler Financial Group position in Q2 2026.
  • Harmony Biosciences made up 0.02% of Nadler Financial Group's portfolio in Q2 2026, its #124 holding.
  • Nadler Financial Group first reported a position in Harmony Biosciences in Q3 2025 and has held it in 3 quarters since.
  • Nadler Financial Group's Harmony Biosciences position peaked at $298K in Q4 2025.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Nadler Financial Group's 13F filing for Q2 2026, filed 30 Jul 2026.